Table 2 Clinical and Laboratory Variables of Patients under Thyroid Nodule Evaluation in a Single Center
From: Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule
Variables | Benign | Malignant | Total | P-value |
|---|---|---|---|---|
Patients (n) | 93 | 50 | 143 | - |
Age (months) | 48.6 ± 11.9 | 44.6 ± 16.5 | 47.2 ± 13.7 | 0.23 |
Age ≥ 45 yrs. (%) | 68.5% | 31.5% | 65% | 0.24 |
Gender (Female) (%) | 86% | 51.3% | 84.6% | 0.52 |
TSH (mU/ml) [median] | 1.37 | 1.82 | 1.47 | 0.11 |
FT4 (mU/ml) [median] | 1.23 | 1.28 | 1.24 | 0.51 |
TAb positively (%) | 23.6% | 15.6% | 21.2% | 0.36 |
Auto-Immune Disease (%) | 24.7% | 14.7% | 21.5% | 0.24 |
Normal Thyroid function (n) | 68 | 42 | 110 | 0.30 |
Hyperthyroidism (Graves) (n) | 15 | 04 | 19 | 0.61 |
Hypothyroidism(n) | 10 | 04 | 14 | 0.15 |